ArticleAmerican journal of translational research2023
Effect of live combined Bifidobacterium and Lactobacillus tablets combined with Soave radical operation on postoperative intestinal flora and immune function in children with Hirschsprung disease.
Article in American journal of translational research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 2 citations in OpenAlex.
- Perioperative Probiotic Supplementation to Reduce Postoperative Infection and Inflammation in Children and Neonates Undergoing Gastrointestinal Surgery: A Systematic Review and Meta-Analysis.Life (Basel, Switzerland) · 2026Review
- Precision minimally invasive strategy for Hirschsprung's disease: from anatomical resection to whole-cycle functional management-a review.Frontiers in pediatrics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate the effects of live combined Bifidobacterium and Lactobacillus tablets combined with Soave radical operation on postoperative intestinal flora and immune function in children with Hirschsprung disease (HD).
methodsA total of 126 cases in the Xi'an Children's Hospital from January 2018-December 2021 were retrospective analyzed. Among them, 60 cases treated with Soave radical operation alone were the control group (CG), and the other 66 cases with live combined Bifidobacterium and Lactobacillus tablets and Soave radical operation were set as the observation group (OG). We compared the treatment efficacy, adverse effects, defecation function, and the number of intestinal flora and IgG and IgA levels at the time of admission and after 3 months of treatment between both groups of children.
resultsThe efficacy efficiency and excellent defecation function rate were dramatically higher in the OG than in the CG after treatment (P<0.05). The bifidobacteria, lactobacilli and enterococcus faecalis were dramatically higher in the OG than in the CG after treatment (P<0.05), and the E. coli was dramatically lower than in the CG (P<0.05). After treatment, IgA and IgG in the OG were higher than those in the CG (P<0.05), and the incidence of postoperative complications was lower than that in the CG (P<0.05).
conclusionLive combined Bifidobacterium and Lactobacillus tablets combined with Soave radical operation can effectively improve intestinal flora dysbiosis and immune function in children with HD. It has a better effect on the ability to defecate and a marked effect on the prevention of complications, which has a high clinical application value.
Indexed as
Identifiers
37303657PMC10250980W4380291945What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.